Clinical practice evaluation of atosiban in preterm labour management in six European countries

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue SUPPL. 3, 2006, Pages 105-110

  Husslein, P ^a   Roura, L C ^b   Dudenhausen, J ^c   Helmer, H ^a   Frydman, R ^d   Rizzo, N ^e   Schneider, D ^f  

^a UNIVERSITY OF VIENNA   (Austria)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e Clinica Ginecologia Ed Ostetrica   (Italy)

^f Ferring Pharmaceuticals AS   (Denmark)

Author keywords

Atosiban; Early administration; Efficacy; Preterm labour; Safety

Indexed keywords

ATOSIBAN; STEROID; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; BLEEDING; BRADYCARDIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HEART RATE; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MECONIUM ILEUS; MULTICENTER STUDY; NEWBORN ANEMIA; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX DILATATION; UTERUS CONTRACTION;

EID: 33845591177     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1046/j.1471-0528.2003.00041.x-i1     Document Type: Article

References (27)

1. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol. 2. Geneva, Switzerland: WHO, 1983.
2. Hall MH, Danielian P, Lamont RF. The importance of preterm birth. In: Elder MG, Lamont RF, Romero R, editors. Preterm Labor. New York, NY: Churchill Livingstone; 1997. pp. 1-28.
3. Steer P, Flint C. Preterm labour and premature rupture of membranes. BMJ 1999;318:1059-62.
4. Maresh M. The obstetric management of preterm labour. Curr Obstet Gynaecol 1992;2:199-206.
5. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990;97:11-25.
6. Lamont RF, Dunlop PD, Crowley P, Levene MI, Elder MG. Comparative mortality and morbidity of infants transferred in utero or postnatally. J Perinat Med 1983;11:200-3.
7. Keirse MJNC. Betamimetic tocolytics in preterm labour. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C, editors. Pregnancy and Childbirth Module. The Cochrane Pregnancy and Childbirth Database. The Cochrane Collaboration. Oxford: Update Software, 1995.
8. Royal College of Obstetricians and Gynaecologists. Tocolytic Drugs for Women in Preterm Labour. Clinical Guideline No. 1(B), 2002. [http:// www.rcog.org.uk/index.asp?PageID=536]. Accessed 18 October 2006.
9. Oei SG, Mol BW, de Kleine MJK, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999;78:783-8.
10. King J, Flenady V, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour: a systematic review of the evidence and a protocol for administration of nifedipine. Aust N Z J Obstet Gynaecol 2003;43:192-8.
11. Lamont RF, Khan KS, Beattie B, Cabero Roura L, Di Renzo GC, Dudenhausen J, et al. The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J Perinat Med 2005;33:287-95.
12. Bal L, Thierry S, Brocas E, Adam M, Van de Louw A, Tenaillon A. Pulmonary edema induced by calcium-channel blockade for tocolysis. Anesth Analg 2004;99:910-11.
13. Hodges R, Barkehall-Thomas A, Tippett C. Maternal hypoxia associated with nifedipine for threatened preterm labour. BJOG 2004;111:380-1.
14. Oei SG, Oei SK, Brolmann HA. Myocardial infarction during nifedipine therapy for preterm labour. N Engl J Med 1999;340:154.
15. Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, Provost-Helou N, Ducloy-Bouthors AS, Puech F, et al. Acute pulmonary oedema during nicardipine therapy for preterm labour, report of 5 cases. Eur J Obstet Gynecol Reprod Biol 2004;113:98-9.
16. Verhaert D, Van Acker R. Acute myocardial infarction during pregnancy. Acta Cardiol 2004;59:331-9.
17. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. Severe hypotension and fetal death due to tocolysiswith nifedipine. BJOG 2005;112:509-10.
18. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173-83.
19. Moutquin J-M, the worldwide atosiban versus beta-agonists survey group. Double-blind, randomised controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety survey. Am J Obstet Gynecol 2000;182:1191-9.
20. Cabrol D, The French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177-85.
21. Maršál K, the worldwide atosiban versus beta-agonists survey group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. Acta Obstet Gynecol Scand 2001;80:413-22.
22. Moutquin J-M, the worldwide atosiban versus beta-agonists survey group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001;108:133-42.
23. Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet 2005;91:10-14.
24. Husslein P, Quartarolo JP. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol. Int J Clin Pract 2003;57:121-7. To be replaced with Acta Ob Gyn in press if accepted for publication.
25. Husslein P, The TREASURE study group. Clinical practice evaluation of atosiban in preterm labour management in six European countries. COGI, Athens, Greece, 2005.
26. Fuentes A, Williams M. Cervical assessment. Clin Obstet Gynecol 1995;38:224-31.
27. Swamy GK, Simhan HN, Gammill HS, Heine RP. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 2005; 50:851-6.